Concomitantly, epithelial markers such as E‐cadherin are down‐regulated, whereas mesenchymal markers including Vimentin, collagen I and β‐catenin are up‐regulated.3 In 2019, a study provided evidence for the positive effects of SLC34A2 on EMT phenotype in glioma cell lines via the EGFR/PI3K/AKT signalling.4 However, the molecular mechanisms that act upstream of these factors in various physiological and pathologic contexts in pancreatic cancer are not well characterized. Here, CDH1 is linked to familial pancreatic carcinoma.